Simulations Plus Inc.

Simulations Plus Inc.

SLP

Get informed when a big investor buys or sells

+ Follow
Market Cap$370.52M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Simulations Plus Inc.Simulations Plus Inc.44.7-6%4.6-
$18.50

Target Price by Analysts

1% upsideSimulations Plus Target Price DetailsTarget Price
$24.23

Current Fair Value

32.3% upside

Undervalued by 32.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$370.52 Million
Enterprise Value$341.22 Million
Dividend Yield$0.24 (-)
Earnings per Share$-3.22
Beta1.31
Outstanding Shares20,170,000

Return

Return on Equity5.83%ROE
Return on Assets5.30%
Return on Invested Capital-46.36%

Valuation & Multiples

P/E Ratio44.7P/E Ratio
PEG-42.45PEG
Price to Sales4.58Price to Sales
Price to Book Ratio3.05Price to Book Ratio
Enterprise Value to Revenue4.16
Enterprise Value to EBIT-5.28
Enterprise Value to Net Income42
Total Debt to Enterprise0.02
Debt to Equity0.04Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
July 13, 2026
EPS Estimate
$0.23
Average shareholder expectation
Revenue Estimate
$20.92 M
Average shareholder expectation

Next Earnings Call

Expected Date
October 28, 2026
EPS Estimate
$0.11
Average shareholder expectation
Revenue Estimate
$17.59 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 6.60%
Total Calls14,400 92.80%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %25.32% 54.77%
Total Invested$92.35M 51.68%
Investors Holding64 97.00%

ESG Score

No data

About Simulations Plus Inc.

108 employees

Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With its subsidiaries, Cognigen, DILIsym Services, and...